´
5417
A. Głuszynska et al. / Tetrahedron Letters 51 (2010) 5415–5418
correlate well with the emission characteristics of ligand 1 in 5%
EtOH which exhibit only a single broad emission band centered
around 550 nm. The position and shape of the long-wavelength
emission band resemble those reported for anthrylvinylpyridinium
derivatives.22 The relative intensities of both fluorescence bands
change with the content of ethanol in solution and can be ascribed
to the extent of dimerization (association) of the ligand. The
reversibility of this association process was confirmed by changing
the solvent mixing order, which gave the same bimodal-emission
spectra at 50% content of EtOH, starting from both 5% EtOH and
pure EtOH solutions of 1.
Preliminary studies on the DNA binding affinity of the ligands
were carried out with calf thymus DNA as a double-stranded
DNA (dsDNA), and 22-mer oligonucleotide (50-AGGGTTAGGGTTA
GGGTTAGG G-30), with a sequence related to human telomere
DNA (G4 DNA), which can form intramolecular G-quadruplex
structures by the folding of a single oligonucleotide molecule.
Small spectral changes were observed in the absorption and emis-
sion spectra of both ligands in the presence of DNA as shown in
Figure 3.
nitrogen) should improve the solubility and DNA binding affinities
of the ligands. Further investigations including new syntheses and
DNA binding studies are in progress.
Acknowledgements
This work was supported by Grant No. N204 004 32/0254 from
the Ministry of Science and Higher Education.
References and notes
1. Li, J.; Li, D.; Han, Y.; Shuang, S.; Dong, Ch. Spectrochim. Acta Part A 2009, 73,
221–225.
2. Ou, T.; Lu, Y.; Tan, J.; Huang, Z.; Wong, K.; Gu, L. Chem. Med. Chem. 2008, 3, 690–
713.
3. Pilch, D. S.; Barbieri, Ch. M.; Rzuczek, S. G.; La Voie, E. J.; Rice, J. E. Biochemie
2008, 90, 1233–1249.
4. De Cian, A.; Lacroix, L.; Douarre, C.; Temime-Smaali, N.; Trentesaux, Ch.; Riou,
J.-F.; Mergny, J.-L. Biochemie 2008, 90, 131–155.
5. Folini, M.; Gandellini, P.; Zaffaroni, N. Biochim. Biophys. Acta 2009, 1792, 309–
316.
6. Mau, A. W. H.; Sasse, W. H. F.; Creaser, I. I.; Sargeson, A. M. New J. Chem. 1986,
10, 589–592.
7. Juskowiak, B.; Ohba, M.; Sato, M.; Takenaka, S.; Takagi, M.; Kondo, H. Bull. Chem.
Soc. Jpn. 1999, 72, 265–277.
8. Głuszyn´ ska, A.; Rozwadowska, M. D. Tetrahedron: Asymmetry 2000, 11, 2359–
These indicate that the ligands interact with both dsDNA, and
G4 DNA, but spectral effects are rather modest. In the case of ligand
1 small quenching and a blue-shift of fluorescence was observed
(Fig. 3A). The fluorescence spectrum of ligand 2 undergoes oppo-
site changes in the presence of DNA, that is, a red-shift and a small
enhancement effect.
2366.
9. Wen, L.; Li, M.; Schlenoff, J. B. J. Am. Chem. Soc. 1997, 119, 7726–7733.
10. Kagan, F.; Birkenmeyer, R. D.; Strube, R. E. J. Am. Chem. Soc. 1959, 81, 3026–
3031.
11. Compound 4: To a vigorously stirred suspension of 9,10-dibromoanthracene
(1.00 g, 3 mmol) in THF (60 mL) under an argon atmosphere at ꢀ72 °C n-BuLi
(1.6 M solution in hexane, 6.25 mL, 8.35 mmol, 1.4 equiv) was added dropwise.
After 1 h, 4-formylmorpholine (0.72 mL, 7.2 mmol, 1.2 equiv) was added at the
same temperature. The yellow clear mixture was kept at ꢀ35 °C for 12 h and
then quenched with 20% NH4Cl (20 mL) at the same temperature. After
warming to rt, phases were separated and the aqueous one was extracted with
Et2O (3 ꢁ 20 mL). The combined organic extracts were dried, and the solvent
evaporated under reduced pressure to afford a crude product which was
crystallized from CH2Cl2/hexane to give 485 mg (70%) of 9-bromoanthracene-
10-carboxaldehyde (4) as yellow crystals. Mp: 210–213 °C [lit.12 207–208 °C
(C6H6)]. Spectral data were identical with literature data.12
12. Gore, P. H.; Gupta, S. D.; Obaji, G. A. J. Prakt. Chem. 1984, 326, 381–384.
13. Compound 5: To a yellow suspension of 9-bromoanthracene-10-carboxaldehyde
(4) (300 mg, 1 mmol) in DMSO (30 mL) CuCN (895 mg, 10 mmol) was added. The
mixture was heated at reflux with stirring until no more substrate was present
(6 h, TLC). After cooling to rt the copper complex of the product was destroyed
with 25% NH4OH (30 mL). The solid was filtered off, washed with H2O (40 mL),
dried, and was crystallized from CH2Cl2/hexane to give 194 mg (81%) of 9-cyano-
10-anthracenocarboxaldehyde (5) a yellow crystals. Mp: 260–263 °C (lit.12 263–
264 °C). Spectral data were identical with literature data.12
It can be speculated, that the poor solubility of the ligands in
aqueous solution, and the tendency to form associates may hamper
efficient intercalation of the ligands to the DNA samples. The intro-
duction of a positive charge into the ligand structure (quaternary
25000
20000
15000
10000
5000
1
A
dsDNA + 1
G4 DNA + 1
14. Olah, G. A.; Ohannesian, L.; Arvanaghi, M. J. Org. Chem. 1984, 49, 3856–3857.
15. Whitaker, K. E.; Snyder, H. R. J. Org. Chem. 1970, 35, 30–32.
16. Wang, C.; Bryce, M. R.; Batsanov, A. S.; Stanley, C. F.; Beeby, A.; Howard, J. A. K.
J. Chem. Soc., Perkin Trans. 2 1997, 1671–1678.
17. Nakatsuji, S.; Matsuda, K.; Uesugi, Y.; Nakashima, K.; Akiyama, S.; Katzer, G.;
Fabian, W. J. Chem. Soc., Perkin Trans. 2 1991, 861–867.
18. Sun, L.; Görner, H. J. Phys. Chem. 1993, 97, 11186–11193.
40000
2
19. Synthesis of nitriles
7 and 8: To a solution of diethyl[(4-cyanophenyl)-
B
methyl]phosphonate9,10 (278 mg, 1.1 mmol) in DMF (1 mL), freshly prepared
MeONa (0.7 mL, 1.62 mmol, 2.3 M/dm3) was added. The ylide was generated at
room temperature in 10 min under an argon atmosphere. After cooling to 0 °C
aldehyde (1 mmol) in DMF (4 mL) was added. The mixture was stirred at this
temperature or at rt until completion of the reaction (TLC). The resulting
precipitatewas filtered and thefiltrate pouredonto ice. Thesolid was filtered, the
combined solids washed with H2O (20 mL) and hexane (20 mL), and dried to give
the crude product. Compound 7: 3 h, 0 °C. The crude product was crystallized
from CH2Cl2/hexane; yellow crystals (65%), mp: 268–270 °C (hexane–CH2Cl2). IR
(KBr) cmꢀ1: 2224 (C„N), 2211 (C„N), 964 (E CH@CH). 1H NMR (CDCl3) d: 6.96
(d, J = 16.7 Hz, 1H, CH@CH), 7.52–7.62 (m, 2H, ArH), 7.72–7.86 (m, 4H, ArH), 8.00
(d, J = 16.5 Hz, 1H, CH@CH), 8.01–8.04 (m, 2H, ArH), 8.32–8.37 (m, 2H, ArH),
8.46–8.50 (m, 2H, ArH). EIMS: m/z (%): 227 (26), 301 (16), 328 (Mꢀ2, 14), 329
(Mꢀ1, 43), 330 (M+, 100), 331 (M+1, 33), 332 (M+2, 11). HRMS calcd for C24H14N2
330.11569. Found 330.11614.Compound 8: 22 h, rt; the TLC-pure product 8 was
used in the next step without further purification; yellow crystals (yield: 55%),
mp: 186–188 °C. IR (KBr) cmꢀ1: 2220 (C„N), 966 (E CH@CH). 1H NMR (CDCl3) d:
1.45 (t, J = 7.1 Hz, 3H, CH2–CH3), 4.38 (q, J = 7.1 Hz, 2H, CH2–CH3), 7.11 (d,
J = 16.5 Hz, 1H, CH@CH), 7.24–7.29 (m, 1H, ArH), 7.39–7.52 (m, 3H, ArH), 7.55 (d,
J = 16.5 Hz, 1H, CH@CH), 7.58–7.69 (m, 5H, ArH), 8.11–8.14 (m, 1H, ArH). EIMS:
m/z (%): 204 (10), 292 (16), 307 (63), 322 (100). HRMS calcd for C23H18N2
322.14700. Found 322.14591.
dsDNA + 2
G4 DNA + 2
30000
20000
10000
0
B
400
500
600
700
800
Wavelength (nm)
Figure 3. Fluorescence emission spectra of ligand 1 (A): (1.62 ꢁ 10ꢀ5 M, 5% EtOH,
10 mM Tris–HCl pH 7.2, kex = 388 nm) and ligand 2 (B): (1.2 ꢁ 10ꢀ5 M, 5% EtOH,
10 mM Tris–HCl pH 7.2, kex = 350 nm) in the absence (black) and the presence of
dsDNA (1.25 equiv, red) and G4 DNA (1.25 equiv, green).
20. Synthesis of oxazolines 1 and 2. Compound 1: To ( )-1-amino-2-propanol
(1.1 mL, 14 mmol) and anhydrous K2CO3 (81.5 mg) in a mixture of ethylene